The AICURA medical team is excited  to announce that our Head of Strategy Augusta Modestino, PhD, and our Chief Medical Officer Dr. Janis Reinelt are participating in Alzheimer’s Association International Conference, taking place in Amsterdam from 16-19 July.

‍

Alzheimer’s Association International Conference (AAIC) is one of the largest and most influential conferences dedicated to Alzheimer's research, bringing together over 5,000 leaders from the global dementia community to share the latest research, treatment strategies, and innovations in Alzheimer’s and related dementias. Among the highlights of the conference is the latest Alzheimer’s clinical trial readouts. These will offer insights into areas such as amyloid and tau biomarkers, tau biology, the use of amyloid- and tau-PET in modelling longitudinal disease processes. The conference will also explore exciting developments in novel fluid biomarkers, and strategies for the inclusion of underrepresented groups in Alzheimer's research will be unveiled.

‍

We are looking forward to gaining insights as we at AICURA work in accelerating clinical research in neurodegenerative diseases by leveraging the power of data x AI. Join us at the conference to discuss how these innovative technologies can improve diagnostic precision and optimize therapeutic strategies for Alzheimer's disease. Together we can improve patient outcomes for such debilitating diseases!

‍